Everolimus EP Impurity B | CAS 1062122-63-7 - Request Quote

Everolimus EP Impurity B is chemically (2S)-1-[[(2R,3R,6S)-2-hydroxy-6-[(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxodocosa-3,5,7,15,19-pentaen-1-yl]-3-methyloxan-2-yl](oxo)acetyl]piperidine-2-carboxylic acid (as per EP) ; (S)-1-{2-[(2R,3R,6S)-2-Hydroxy-6-{(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxodocosa-3,5,7,15,19-pentaen-1-yl}-3-methyltetrahydro-2H-pyran-2-yl]-2-oxoacetyl}piperidine-2-carboxylic acid (as per USP). It is also known as Everolimus 19-Ene Open-Ring (USP) ; seco Everolimus ; (19E/Z)-seco-[4-O-(2-Hydroxyethyl)] Rapamycin. Everolimus EP Impurity B is supplied with detailed characterization data compliant with regulatory guideline. Everolimus EP Impurity B can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Everolimus .

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.